Skip to main content

What the FDA labels say about taking them together

Itraconazole and repaglinide

Itraconazole's FDA label of July 13, 2026 names repaglinide in its drug interactions section, and repaglinide's label names itraconazole too. The itraconazole label: “Antidiabetic Drugs Repaglinide Saxagliptin Monitor for adverse reactions.”

Check it at the source: the itraconazole FDA label on DailyMed (effective July 13, 2026, Janssen Pharmaceuticals, Inc.); the repaglinide FDA label on DailyMed (effective May 2, 2025, Chartwell RX, LLC).

What does the itraconazole label say about repaglinide?

Itraconazole label, drug interactions

Antidiabetic Drugs Repaglinide Saxagliptin Monitor for adverse reactions.

Source: FDA drug label (SPORANOX), Janssen Pharmaceuticals, Inc., effective July 13, 2026 (SPL set a4d555fa-787c-40fb-bb7d-b0d4f7318fd0), via openFDA; the full label on DailyMed

What does the repaglinide label say about itraconazole?

Repaglinide label, drug interactions

CYP2C8 and CYP3A4 Inhibitors Intervention: Repaglinide tablets dose reductions and increased frequency of glucose monitoring may be required when co-administered. Examples: Drugs that are known to inhibit CYP3A4 include antifungal agents (ketoconazole, itraconazole) and antibacterial agents (clarithromycin, erythromycin). Drugs that are known to inhibit CYP2C8 include trimethoprim, gemfibrozil, montelukast, deferasirox, and clopidiogrel.

Source: FDA drug label (Repaglinide), Chartwell RX, LLC, effective May 2, 2025 (SPL set cb995e92-295e-4638-a064-978211f5afe1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

11Itraconazole generic labelers
7Repaglinide generic labelers
ItraconazoleRepaglinide
Labeled forFungal infectionsType 2 diabetes
Boxed warningYesNo
Pharmacy cost (NADAC)$0.910 per capsule 100 mg capsule$0.0987 per tablet 1 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?